Hepatitis Monthly | Issue 18 (1)

15

Jan

2018

<b><i class='fa-duotone fa-file-image me-1 text-warning'></i></b>

Review Article

Prevalence Rate of Hepatitis B Virus in Pregnancy: Implications From a Systematic Review and Meta-Analysis of Studies Published From 2000 to 2016

Masoud Behzadifar, Nicola Luigi Bragazzi, Rabeh Movagharnia, Haniye Sadat Sajadi, Sanaz Heidarvand Ghelichi, Morteza Salemi, et al.

|

Final Published

| https://doi.org/10.5812/hepatmon.14574

24

Jan

2018

Research Article

Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey

Ali Asan^* , Murat Sayan, Sila Akhan, Suda Tekin Koruk, Bilgehan Aygen, Fatma Sirmatel, et al.

|

Final Published

| https://doi.org/10.5812/hepatmon.12472

20

Jan

2018

Research Article

Safety and Efficacy of Direct-Acting Antivirals in Transfusion-Dependent Thalassemic Patients with Chronic Hepatitis C

Simona Onali, Ivana Maida, Cinzia Balestrieri, Francesco Arcadu, Enrico Urru, Davide Porcu, et al.

|

Final Published

| https://doi.org/10.5812/hepatmon.61453

14

Jan

2018

Research Article

Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis

Negar Rezaei, Farshad Farzad Far, Sara Khademiureh, Ali Sheidaei, Kimiya Gohari, Farnaz Delavari, et al.

|

Final Published

| https://doi.org/10.5812/hepatmon.62009

14

Jan

2018

Research Article

Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

Ligita Jancoriene^* , Katazyna Polubenko, Edita Kazenaite, Arida Buivydiene, Jolita Jakutiene, Ieva Tolmane

, et al.

|

Final Published

| https://doi.org/10.5812/hepatmon.62105

20

Jan

2018

Case Report

Reactivation of Hepatitis B Virus During Treatment of Hepatitis C Genotype 3 with Daclatasvir and Sofosbuvir in a Patient with Dual Infection of Hepatitis B and Hepatitis C Virus

Georgios Zacharakis^* , Jaman Alzahrani

|

Final Published

| https://doi.org/10.5812/hepatmon.12531

Archive

Prevalence Rate of Hepatitis B Virus in Pregnancy: Implications From a Systematic Review and Meta-Analysis of Studies Published From 2000 to 2016

Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey

Safety and Efficacy of Direct-Acting Antivirals in Transfusion-Dependent Thalassemic Patients with Chronic Hepatitis C

Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis

Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

Reactivation of Hepatitis B Virus During Treatment of Hepatitis C Genotype 3 with Daclatasvir and Sofosbuvir in a Patient with Dual Infection of Hepatitis B and Hepatitis C Virus

Cookie Setting